Using Dexamethasone with Ropivacaine for Pain Management in Hip Surgery
Pericapsular Nerve Group Block with 20 Ml 0.2% Ropivacaine Vs 10ml 0.2% Ropivacaine and Dexamethasone in Total Hip Arthroplasty: a Randomized Controlled Trial
This study is testing if adding Dexamethasone to a pain block can help older patients have less pain after hip surgery while using less of the numbing medicine Ropivacaine.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 65 Years to 100 Years |
| Sex | All |
| Sponsor | Poznan University of Medical Sciences Academic / other |
| Locations | 1 site (Poznan, Poznań) |
| Trial ID | NCT06470334 on ClinicalTrials.gov |
What this trial studies
This study investigates whether adding Dexamethasone to the Periarticular Nerve Group Block can reduce the required dose of Ropivacaine in patients undergoing Total Hip Arthroplasty. The goal is to alleviate severe pain associated with hip surgery while minimizing opioid use and its side effects. The study focuses on elderly patients, who are particularly vulnerable to pain and complications from surgery. By employing regional anesthesia techniques, the research aims to enhance postoperative recovery and comfort.
Who should consider this trial
Good fit: Ideal candidates are patients aged 65 to 100 scheduled for total hip arthroplasty who can provide informed consent and report their symptoms.
Not a fit: Patients who are unable to provide informed consent due to cognitive impairment or language barriers will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved pain management and reduced opioid consumption for patients undergoing hip surgery.
How similar studies have performed: Other studies have shown promising results with similar approaches in pain management during orthopedic procedures, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients scheduled for total hip arthroplasty * patients aged \>65 and \<100 years * patients able to provide informed consent * patients able to reliably report symptoms to the research team Exclusion Criteria: * inability to provide first-party consent due to cognitive impairment or a language barrier
Where this trial is running
Poznan, Poznań
- Poznan University of Medical Sciences — Poznan, Poznań, Poland (Recruiting)
Study contacts
- Study coordinator: Malgorzata Domagalska, M.D. Ph.D.
- Email: mdomagalska@ump.edu.pl
- Phone: (61) 873-83-03
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.